PuriBlood Medical Co.,Ltd. (6847) Stock Statistics & Valuation Metrics
Total Valuation
PuriBlood Medical Co.,Ltd. has a market cap or net worth of TWD 1.20B. The enterprise value is ―.
- Market Cap
- TWD 1.20B
- Enterprise Value
- ―
Share Statistics
PuriBlood Medical Co.,Ltd. has 16,930,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 16,930,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
PuriBlood Medical Co.,Ltd.’s return on equity (ROE) is -0.28 and return on invested capital (ROIC) is -17.36%.
- Return on Equity (ROE)
- -0.28
- Return on Assets (ROA)
- -0.16
- Return on Invested Capital (ROIC)
- -17.36%
- Return on Capital Employed (ROCE)
- -0.19
- Revenue Per Employee
- 2.17M
- Profits Per Employee
- -1.03M
- Employee Count
- 38
- Asset Turnover
- 0.35
- Inventory Turnover
- 1.88
Valuation Ratios
The current PE Ratio of PuriBlood Medical Co.,Ltd. is -17.35. PuriBlood Medical Co.,Ltd.’s PEG ratio is 0.06.
- PE Ratio
- -17.35
- PS Ratio
- 14.29
- PB Ratio
- 8.85
- Price to FCF
- -35.25
- Price to Operating Cash Flow
- -29.98
- PEG Ratio
- 0.06
Income Statement
In the last 12 months, PuriBlood Medical Co.,Ltd. had revenue of 82.33M and earned -39.00M in profits. Earnings per share was -2.74.
- Revenue
- 82.33M
- Gross Profit
- 32.31M
- Operating Income
- -33.44M
- Pretax Income
- -38.77M
- Net Income
- -39.00M
- EBITDA
- -29.89M
- Earnings Per Share (EPS)
- -2.74
Cash Flow
In the last 12 months, operating cash flow was -32.27M and capital expenditures -386,000, giving a free cash flow of -32.66M billion.
- Operating Cash Flow
- -32.27M
- Free Cash Flow
- -32.66M
- Free Cash Flow per Share
- -2.30
Dividends & Yields
PuriBlood Medical Co.,Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2.84%
- Earnings Yield
- -5.77%
Stock Price Statistics
- Beta
- 0.30
- 52-Week Price Change
- -4.75%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 47.56
- Average Volume (3m)
- 32.17K
Financial Position
PuriBlood Medical Co.,Ltd. as a current ratio of 2.12, with Debt / Equity ratio of 36.40%
- Current Ratio
- 2.12
- Quick Ratio
- 1.67
- Debt to Market Cap
- 0.03
- Net Debt to EBITDA
- 0.31
- Interest Coverage Ratio
- -31.13
Taxes
In the past 12 months, PuriBlood Medical Co.,Ltd. has paid 237.00K in taxes.
- Income Tax
- 237.00K
- Effective Tax Rate
- -0.01
Enterprise Valuation
PuriBlood Medical Co.,Ltd. EV to EBITDA ratio is -26.14, with an EV/FCF ratio of -35.49.
- EV to Sales
- 14.39
- EV to EBITDA
- -26.14
- EV to Free Cash Flow
- -35.49
- EV to Operating Cash Flow
- -35.91
Balance Sheet
PuriBlood Medical Co.,Ltd. has TWD 39.78M in cash and marketable securities with TWD 47.46M in debt, giving a net cash position of -TWD 7.68M billion.
- Cash & Marketable Securities
- TWD 39.78M
- Total Debt
- TWD 47.46M
- Net Cash
- -TWD 7.68M
- Net Cash Per Share
- -TWD 0.45
- Tangible Book Value Per Share
- TWD 7.25
Margins
Gross margin is 19.73%, with operating margin of -59.06%, and net profit margin of -69.30%.
- Gross Margin
- 19.73%
- Operating Margin
- -59.06%
- Pretax Margin
- -67.54%
- Net Profit Margin
- -69.30%
- EBITDA Margin
- -55.05%
- EBIT Margin
- -64.34%
Analyst Forecast
The average price target for PuriBlood Medical Co.,Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -31.36%
- EPS Growth Forecast
- -647.19%
